Zydus Mitomycin 2 Injection IP 2 mg About
Seize instant savings and benefit from the lowest price promotion on the valuable Zydus Mitomycin 2 Injection IP 2 mg. This illustrious and sought-after antineoplastic agent is prescribed for the treatment of various cancers and contains 2 mg Mitomycin per sterile single-use vial. Suitable for intravenous administration or as directed by a physician, it comes in a secure vial with an outer carton. It holds major approvals from regulatory bodies in Canada, the EU, UK, USA, and Australia. Each batch and expiry detail is clearly labeled for trusted use. Storage between 2C to 8C ensures product integrity.
Treatment Excellence & Specific Usage
Zydus Mitomycin 2 Injection IP 2 mg is explicitly indicated as an antineoplastic (anticancer) agent, administered under medical supervision. Its application focuses on the targeted treatment of various cancers, leveraging the potent effects of Mitomycin. The sterile, single-use vial ensures both safety and efficacy for each patient. This formulation is reconstituted as instructed by a physician, making it a reliable choice for hospitals and clinics seeking the best in cancer care solutions.
Packaging, Supply & Market Value Insights
Packaged in a vial with an outer carton and protected with a barcode for secure identification, Zydus Mitomycin 2 Injection offers excellent valuation in terms of safety and supply assurance. Each unit's batch number and expiry are clearly marked, reflecting the product's high market value. With a steady supply ability and clear sample policy-charges may apply based on order-buyers benefit from consistent access, ensuring timely fulfillment for all valued healthcare providers and traders.
FAQ's of Zydus Mitomycin 2 Injection IP 2 mg:
Q: How should Zydus Mitomycin 2 Injection IP 2 mg be administered?
A: Zydus Mitomycin 2 Injection IP 2 mg is administered intravenously or as directed by a physician, following reconstitution with the recommended diluent.
Q: What are the key indications for using this injection?
A: This injection is primarily indicated for cancer treatment, functioning as a potent antineoplastic agent under medical supervision.
Q: When should the Zydus Mitomycin 2 Injection be stored and used?
A: It should be stored between 2C to 8C, protected from light, and used before the specified expiry date, which is marked on both the vial and carton.
Q: Where is the product approved for export or import?
A: Zydus Mitomycin 2 Injection IP 2 mg is approved for export/import in Canada, the European Union, the UK, USA, and Australia.
Q: What is the process for verifying batch and expiry details?
A: Batch number and expiry details are mentioned on both the vial and the outer carton, allowing for easy verification before use.